Increasingly people are learning about Semaglutide and other GLP-1 therapies due to their observed impact in body composition changes. Originally intended to address type 2 diabetes , these GLP-1 receptor agonists work by mimicking a body's hormone that regulates hunger and slows gastric motility . This dual action can create significant slimming